NCT02935894View on ClinicalTrials.gov

Investigating the Stability, Variability and Mechanism of Incorporation of Lipid Mediators Into Eccrine Sweat

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 28, 2016

Primary Completion Date

June 8, 2017

Study Completion Date

June 8, 2017

Conditions
Stability & Variability of Lipid-derived Molecules in Sweat
Interventions
DRUG

Ibuprofen

400 mg ibuprofen given to inhibit cyclooxygenase metabolism

OTHER

Physiological induction of sweating

15 minutes exercise at 60-80% oxygen consumption to induce sweating

DRUG

Pilocarpine

Iontophoresis with a 1.5 milliampere (mA) current using a gel disc containing a 5% pilocarpine nitrate solution to induce sweating

Trial Locations (1)

95616

Western Human Nutrition Research Center, Davis

All Listed Sponsors
collaborator

University of California, Davis

OTHER

lead

USDA, Western Human Nutrition Research Center

FED

NCT02935894 - Investigating the Stability, Variability and Mechanism of Incorporation of Lipid Mediators Into Eccrine Sweat | Biotech Hunter | Biotech Hunter